Long-Term Predictors of Clinical Events after Off-Label Use of Drug-Eluting Stent beyond 1 Year

Kyeong-Ho YUN; Jum-Suk KO; Sang-Jae RHEE; Eun-Mi LEE; Nam-Jin YOO; Nam-Ho KIM; Seok-Kyu OH; Jin-Won JEONG.
Korean Circulation Journal ; : 161-167, 2013.
Artículo en Inglés | WPRIM | ID: wpr-34370

Documentos relacionados

  1. Off-label drug use in neonates and infants in Spain: A five-year observational study.
  2. [Approved systemic therapies in dermatology].
  3. Optimizing therapeutic decision-making for off-label medicines use: A scoping review and consensus recommendations for improving practice and research<sup></sup>.
  4. Off-label use information in electronic drug information resources.
  5. Judicial and legislative practice and related suggestions on off-label drug use in China.
  6. Off-label and unlicensed drug use in children population.
  7. A guided framework for assessing off-label medication use in psychiatry.
  8. Paving the Path for Sustainable and Responsible Off-Label Use of Pharmaceutical Products in Europe.
  9. Long-Term Safety Profile and Off-Label Use of JAK Inhibitors in Dermatological Disorders.
  10. Long-Term Safety Profile and Off-Label Use of JAK Inhibitors in Dermatological Disorders.